Nishitha M Reddy

Nishitha M Reddy

UNVERIFIED PROFILE

Are you Nishitha M Reddy?   Register this Author

Register author
Nishitha M Reddy

Nishitha M Reddy

Publications by authors named "Nishitha M Reddy"

Are you Nishitha M Reddy?   Register this Author

39Publications

923Reads

7Profile Views

Durable responses in refractory autoimmune hemolytic anemia with alemtuzumab.

J Oncol Pharm Pract 2019 Apr 15;25(3):706-709. Epub 2018 Jan 15.

2 Department of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155217750463DOI Listing
April 2019

Treatment of newly diagnosed primary central nervous system lymphoma: current and emerging therapies.

Leuk Lymphoma 2019 01 9;60(1):6-18. Epub 2018 May 9.

a Division of Hematology/Oncology, Department of Medicine , Vanderbilt University Medical Center , Nashville , TN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1466296DOI Listing
January 2019

Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planning.

Br J Haematol 2017 11 13;179(4):674-676. Epub 2016 Jul 13.

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14236DOI Listing
November 2017

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.

J Clin Oncol 2017 Jul 5;35(20):2260-2267. Epub 2017 May 5.

Daniel J. Landsburg and Anthony R. Mato, University of Pennsylvania; James N. Gerson and Stefan K. Barta, Temple University, Philadelphia, PA; Marissa K. Falkiewicz, Robert Wood Johnson Medical School, New Brunswick; Christina Howlett, Tatyana Feldman, and Anthony R. Mato, Hackensack University Medical Center, Hackensack, NJ; Joseph Maly and Kristie A. Blum, Ohio State University, Columbus; Brian T. Hill, Cleveland Clinic, Cleveland, OH; Shaoying Li and L. Jeffrey Medeiros, MD Anderson Cancer Center, Houston, TX; Pallawi Torka and Francisco Hernandez-Ilizaliturri, Roswell Park Cancer Institute, Buffalo; Jennifer K. Lue and Jennifer E. Amengual, Columbia University, New York, NY; Nishitha M. Reddy, Vanderbilt University, Nashville, TN; Arun Singavi and Timothy S. Fenske, Medical College of Wisconsin, Milwaukee, WI; Julio C. Chavez, Moffitt Cancer Center, Tampa, FL; Jason B. Kaplan, Amir Behdad, and Adam M. Petrich, Northwestern University, Evanston; Adam M. Petrich, AbbVie, North Chicago; David J. Peace, University of Illinois, Urbana; Sunita Nathan, Rush University, Chicago, IL; Martin A. Bast and Julie M. Vose, University of Nebraska, Lincoln, NE; Adam J. Olszewski, Brown University, Providence, RI; Cristiana Costa and Frederick Lansigan, Dartmouth College, Hanover, NH; Oscar Calzada and Jonathon B. Cohen, Emory University, Atlanta, GA; Xavier Rivera and Daniel O. Persky, University of Arizona, Tucson, AZ; and Ryan D. Cassaday, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366297PMC
July 2017

Management of Patients With Histologic Transformation.

Authors:
Nishitha M Reddy

Clin Lymphoma Myeloma Leuk 2017 07;17S:S100-S104

Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.02.020DOI Listing
July 2017

Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic Malignancies.

Curr Hematol Malig Rep 2017 06;12(3):257-267

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, 3927 The Vanderbilt Clinic, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-017-0369-yDOI Listing
June 2017

Beyond Epstein-Barr virus: genetic predisposition of natural killer T-cell lymphoma.

Lancet Oncol 2016 09 25;17(9):1176-7. Epub 2016 Jul 25.

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30205-4DOI Listing
September 2016

Clinical Reasoning: A 52-year-old man with diplopia and ataxia.

Neurology 2016 09;87(13):e140-3

From the Departments of Neurology (M.J.B., S.P., P.M.), Medicine (Infectious Disease) and Health Policy (K.C.B.), and Medicine (Hematology and Oncology) (N.M.R.), Vanderbilt University Medical Center, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003150DOI Listing
September 2016

CD30 expression and its correlation with MYC rearrangement in de novo diffuse large B-cell lymphoma.

Eur J Haematol 2016 Jul 1;97(1):39-47. Epub 2015 Oct 1.

Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12680DOI Listing
July 2016

High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.

Am J Surg Pathol 2016 Feb;40(2):253-61

Departments of *Pathology‡Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN†Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000542DOI Listing
February 2016

Alternative intensive induction chemotherapeutic regimens in MYC expressing diffuse large B-cell lymphoma.

Leuk Lymphoma 2015 Mar 17;56(3):797-800. Epub 2014 Jul 17.

Division of Hematology and Oncology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.928937DOI Listing
March 2015

Increased serum tumor necrosis factor α levels in patients with lenalidomide-induced hypothyroidism.

Exp Hematol 2015 Feb 28;43(2):74-8. Epub 2014 Oct 28.

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2014.10.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002942PMC
February 2015

Stem cell transplantation in Hodgkin lymphoma.

Hematol Oncol Clin North Am 2014 Dec 26;28(6):1097-112. Epub 2014 Sep 26.

Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 298, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2014.08.011DOI Listing
December 2014

Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma.

Onco Targets Ther 2014 24;7:1971-7. Epub 2014 Oct 24.

Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S59269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216035PMC
November 2014

Consolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspective.

Ther Adv Hematol 2014 Oct;5(5):153-67

Vanderbilt University Medical Center, 3927 The Vanderbilt Clinic, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620714547327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199091PMC
October 2014

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

Exp Hematol 2014 Jan 2;42(1):39-45. Epub 2013 Oct 2.

Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2013.09.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002948PMC
January 2014

Management of T-cell lymphomas: overcoming challenges and choosing the best treatment.

Semin Hematol 2014 Jan 19;51(1):1-4. Epub 2013 Nov 19.

Section of Hematology and Stem Cell Transplantation Division of Hematology/Oncology Department of Medicine Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2013.11.009DOI Listing
January 2014

Chemotherapeutic advancements in peripheral T-cell lymphoma.

Semin Hematol 2014 Jan 14;51(1):17-24. Epub 2013 Nov 14.

Division of Hematology and Oncology, Department of Medicine, Tufts University School of Medicine, Medford, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2013.11.006DOI Listing
January 2014

Novel therapeutic strategies for cutaneous T-cell lymphoma in advanced stages.

Semin Hematol 2014 Jan 14;51(1):35-41. Epub 2013 Nov 14.

Division of Hematology/Oncology(,) Vanderbilt-Ingram Cancer Center, Nashville, TN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2013.11.004DOI Listing
January 2014

Immune surveillance and lymphoid malignancy in immunocompromised host.

Am J Blood Res 2013 5;3(2):91-101. Epub 2013 May 5.

Division of Hematology and stem cell transplantation, Department of Medicine, Vanderbilt University Medical Center Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649811PMC
May 2013